Storys zum Thema Medizin, Gesundheit

Bosch Healthcare Solutions GmbH

Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes

Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...

Dr. Reddy's Laboratories SA

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment

Helmholtz Munich

Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets

Sysmex Europe SE

Sysmex establishes new branch office in Finland

Nestlé Nespresso SA

NESPRESSO WILL INVEST 20 MILLION USD IN DRC TO SUPPORT THE COFFEE GROWING COMMUNITY AND THE REVIVAL OF THE SPECIALTY COFFEE

Vevey, Switzerland (ots/PRNewswire) - Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water. Nespresso aims to continue to support the local community and economy by investing 20 ...

ARTCLINE GmbH

ARTCLINE successfully completes capital increases of EUR 4.4 million

Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...

Norgine

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...

STADA Arzneimittel AG

Press release: STADA continues with double-digit sales and profit growth in 2023

FDX Fluid Dynamix GmbH

4

FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX

DHL Group

2

PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador

RHEACELL GmbH und Co. KG

Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘

LTS Lohmann Therapie-Systeme AG

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

Helmholtz Munich

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Koehler Group

Extension of Wastewater Treatment Plant at Koehler Paper in Kehl

Leipzig Tourismus und Marketing GmbH

5

Pioneering Heart Surgery and Medical Congresses in Leipzig

ARTTIC Innovation GmbH

iMEDCAP: EU-Projekt leistet Pionierarbeit bei der Rettung verwundeter Soldaten

ARTTIC Innovation GmbH

iMEDCAP: European project to pioneer the rescue of wounded soldiers from inaccessible areas

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Universität Mannheim

Discrimination Impairs Mental Health Directly and Indirectly

Discrimination Impairs Mental Health Directly and Indirectly Up to now, there was some indication that discrimination negatively affects a person’s mental health and well-being. With a meta study, female researchers of the University of Mannheim show the clear negative effects of discrimination for the first time. The systematic meta study of Christine Emmer, Julia Dorn, and Professor Dr. Jutta Mata, holder of the ...

Helmholtz Munich

What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications

Acousia Therapeutics GmbH

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...

Sysmex Europe SE

Strengthening the Direct Sales and Service System for Business Expansion in Italy

Biomay AG

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service